AAAAAA

   
Results: 1-25 | 26-41 |
Results: 26-41/41
Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma
Authors: Choi, LMR Kim, NW Zuo, JJ Gerbing, R Stram, D Lukens, JN Matthay, KK Seeger, RC Reynolds, CP
Citation: Lmr. Choi et al., Telomerase activity by TRAP assay and telomerase RNA (hTR) expression are predictive of outcome in neuroblastoma, MED PED ONC, 35(6), 2000, pp. 647-650
Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors
Authors: Park, JR Slattery, J Gooley, T Hawkins, D Lindsley, K Villablanca, JG Matthay, KK Sanders, JE
Citation: Jr. Park et al., Phase I topotecan preparative regimen for high-risk neuroblastoma, high-grade glioma, and refractory/recurrent pediatric solid tumors, MED PED ONC, 35(6), 2000, pp. 719-723
Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular- A report from the Children's Cancer Group
Authors: Umehara, S Nakagawa, A Matthay, KK Lukens, JN Seeger, RC Stram, DO Gerbing, RB Shimada, H
Citation: S. Umehara et al., Histopathology defines prognostic subsets of ganglioneuroblastoma, nodular- A report from the Children's Cancer Group, CANCER, 89(5), 2000, pp. 1150-1161
A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma
Authors: Fernandez, MC Krailo, MD Gerbing, RR Matthay, KK
Citation: Mc. Fernandez et al., A phase I dose escalation of combination chemotherapy with granulocyte-macrophage-colony stimulating factor in patients with neuroblastoma, CANCER, 88(12), 2000, pp. 2838-2844
Is there a role for retinoids to treat minimal residual disease in neuroblastoma?
Authors: Matthay, KK Reynolds, CP
Citation: Kk. Matthay et Cp. Reynolds, Is there a role for retinoids to treat minimal residual disease in neuroblastoma?, BR J CANC, 83(9), 2000, pp. 1121-1123
Treatment of advanced neuroblastoma: The US experience
Authors: Matthay, KK Castleberry, RP
Citation: Kk. Matthay et Rp. Castleberry, Treatment of advanced neuroblastoma: The US experience, NEUROBLASTOMA, 2000, pp. 417-436
Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival
Authors: DuBois, SG Kalika, Y Lukens, JN Brodeur, GM Seeger, RC Atkinson, JB Haase, GM Black, CT Perez, C Shimada, H Gerbing, R Stram, DO Matthay, KK
Citation: Sg. Dubois et al., Metastatic sites in stage IV and IVS neuroblastoma correlate with age, tumor biology, and survival, J PED H ONC, 21(3), 1999, pp. 181-189
Congenital leukemia: Successful treatment of a newborn with t(5;11)(q31;q23)
Authors: Fernandez, MC Weiss, B Atwater, S Shannon, K Matthay, KK
Citation: Mc. Fernandez et al., Congenital leukemia: Successful treatment of a newborn with t(5;11)(q31;q23), J PED H ONC, 21(2), 1999, pp. 152-157
Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas
Authors: Guo, C White, PS Weiss, MJ Hogarty, MD Thompson, PM Stram, DO Gerbing, R Matthay, KK Seeger, RC Brodeur, GM Maris, JM
Citation: C. Guo et al., Allelic deletion at 11q23 is common in MYCN single copy neuroblastomas, ONCOGENE, 18(35), 1999, pp. 4948-4957
Institutional review board review of research reported in the Journal of Clinical Oncology - Reply 1
Authors: Matthay, KK
Citation: Kk. Matthay, Institutional review board review of research reported in the Journal of Clinical Oncology - Reply 1, J CL ONCOL, 17(8), 1999, pp. 2625-2626
Molecular biology of neuroblastoma
Authors: Maris, JM Matthay, KK
Citation: Jm. Maris et Kk. Matthay, Molecular biology of neuroblastoma, J CL ONCOL, 17(7), 1999, pp. 2264-2279
Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid
Authors: Matthay, KK Villablanca, JG Seeger, RC Stram, DO Harris, RE Ramsay, NK Swift, P Shimada, H Black, CT Brodeur, GM Gerbing, RB Reynolds, CP
Citation: Kk. Matthay et al., Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid, N ENG J MED, 341(16), 1999, pp. 1165-1173
Somatization, anxiety and depression as measures of health-related qualityof life of children/adolescents with cancer
Authors: Challinor, JM Miaskowski, CA Franck, LS Slaughter, RE Matthay, KK Kramer, RF Veatch, JJ Paul, SM Amylon, MD Moore, IM
Citation: Jm. Challinor et al., Somatization, anxiety and depression as measures of health-related qualityof life of children/adolescents with cancer, INT J CANC, 1999, pp. 52-57
Implementation of a combined X-ray CT-scintillation camera imaging system for localizing and measuring radionuclide uptake: Experiments in phantoms and patients
Authors: Tang, HR Brown, JK Da Silva, AJ Matthay, KK Price, DC Huberty, JP Hawkins, RA Hasegawa, BH
Citation: Hr. Tang et al., Implementation of a combined X-ray CT-scintillation camera imaging system for localizing and measuring radionuclide uptake: Experiments in phantoms and patients, IEEE NUCL S, 46(3), 1999, pp. 551-557
The International Neuroblastoma Pathology classification (the Shimada system)
Authors: Shimada, H Ambros, IM Dehner, LP Hata, J Joshi, VV Roald, B Stram, DO Gerbing, RB Lukens, JN Matthay, KK Castleberry, RP
Citation: H. Shimada et al., The International Neuroblastoma Pathology classification (the Shimada system), CANCER, 86(2), 1999, pp. 364-372
Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein
Authors: Loh, KC Matthay, KK Hoover, M Bracho, FA Cortez, AB Conte, FA Albanese, CT Miller, TR Price, DC Flores, AJ Kaviani, A Shoback, D
Citation: Kc. Loh et al., Hypercalcemia in malignant paraganglioma due to parathyroid hormone-related protein, HORMONE RES, 50(4), 1998, pp. 217-221
Risultati: 1-25 | 26-41 |